-Eleftherios P Diamandis Researcher Activity Profile

Research Author Detailed Information 

Eleftherios P Diamandis Publication Rate By Year

Eleftherios P Diamandis has published 1 paper(s) in 2003, 4 paper(s) in 2006, 23 paper(s) in 2007, 2 paper(s) in 2008, for a total of 30 research publications in total.

Eleftherios P Ep Diamandis Author Information

LAST NAME: diamandis

FIRST NAME: Eleftherios P

INITIALS: ep

AFFILIATION:

Papers

Eleftherios P Diamandis's Publication Record

1. Ovarian cancer specific kallikrein profile in effusions. Year Published: 2007
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA. ishi@jhmi.edu
2. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma. Year Published: 2006
Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.
3. Proteinase-activated receptors, targets for kallikrein signaling. Year Published: 2006
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada.
4. Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. Year Published: 2007
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
5. PSA and other tissue kallikreins for prostate cancer detection. Year Published: 2007
6. [In Process Citation] Year Published: 2007
7. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, University of Toronto, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto M5G 1X5, ON, Canada.
8. Defining the extended substrate specificity of kallikrein 1-related peptidases. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, University of Toronto and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
9. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1X5, Canada.
10. Mitochondrial genome deletion AIDS in the identification of false- and true-negative prostate needle core biopsy specimens. Year Published: 2007
Genesis Genomics, Thunder Bay, Canada.
11. PSA and other tissue kallikreins for prostate cancer detection. Year Published: 2007
12. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Year Published: 2007
Authors' Affiliations: The Fred Hutchinson Cancer Research Center, Seattle, Washington.
13. Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature. Year Published: 2007
14. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada.
15. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, University of Toronto, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto M5G 1X5, ON, Canada.
16. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Year Published: 2007
The Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
17. Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens. Year Published: 2007
Genesis Genomics, Thunder Bay, Canada.
18. POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma? Year Published: 2007
19. Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature. Year Published: 2007
Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. yousefg@smh.toronto.on.ca
20. [In Process Citation] Year Published: 2007
21. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada.
22. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Year Published: 2003
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
23. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Year Published: 2006
Centre for Immunology at St. Vincent's Hospital, Sydney, Australia.
24. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network. Year Published: 2006
25. Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens. Year Published: 2007
Genesis Genomics, Thunder Bay, Canada.
26. Defining the extended substrate specificity of kallikrein 1-related peptidases. Year Published: 2007
Department of Laboratory Medicine and Pathobiology, University of Toronto and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
27. Human Kallikrein-related Peptidase 14 (KLK14) Is a New Activator Component of the KLK Proteolytic Cascade: POSSIBLE FUNCTION IN SEMINAL PLASMA AND SKIN. Year Published: 2008
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G-1L5, Canada and the Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
28. POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma? Year Published: 2007
29. Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature. Year Published: 2007
Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. yousefg@smh.toronto.on.ca
30. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin. Year Published: 2008
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G-1L5, Canada.